ClinicalTrials.Veeva

Menu

Implantable Cardioverter Defibrillators And Magnetic Resonance Imaging of the Heart at 1.5 Tesla

U

University Hospital Bonn (UKB)

Status

Unknown

Conditions

Defibrillators, Implantable
Heart Failure, Congestive

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

To evaluate short-term and long-term effects by MR imaging on the technical and functional status of implantable cardioverter defibrillators.

Full description

The presence of an implantable cardioverter defibrillators (ICD) is currently considered an absolute contraindication to MR imaging, and most patients with PM are excluded from having MRI. As a result from studies such as MADIT I, MADIT II, SCDHeft etc. the number of patients with ICDs has been continuously growing over the past years, ans this development will continue.

The aim of this study is to develop a strategy for safe performance of MR imaging at 1.5T, which included restriction of specific absorption rate (SAR) values to minimize the risk of lead heating, and ICD reprogramming to avoid interference from time varying gradient fields. The safety of this approach is then evaluated in a large group of ICD patients including assessment of potential myocardial thermal injury by measuring serum troponin I and pacing capture thresholds, and performing a follow-up 6 weeks after MR imaging to evaluate long-term effects.

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Implantable Cardioverter Defibrillator
  • congestive heart failure
  • informed consent

Exclusion criteria

  • Non-MRI-compatible implants

Trial contacts and locations

1

Loading...

Central trial contact

Torsten Sommer, MD; Claas P Naehle, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems